Pharmaceutical removal from wastewater by ferrate(VI) and preliminary effluent toxicity assessments by the zebrafish embryo model

Microchemical Journal

Volumn 110, Issue , 2013, Pages 239-245

  Jiang, Jia Qian ^a   Zhou, Zhengwei ^a   Patibandla, Srinath ^a   Shu, Xinhua ^a  

^a GLASGOW CALEDONIAN UNIVERSITY   (United Kingdom)

Author keywords

Embryo toxicity assay; Ferrate(VI); Pharmaceutical residual; Wastewater treatment

Indexed keywords

EID: 84877358619     PISSN: 0026265X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.microc.2013.04.002     Document Type: Article

References (50)

1. Wang L., Ying G.G., Zhao J.L., Yang X.B., Chen F. Occurrence and risk assessment of acidic pharmaceuticals in the Yellow River, Hai River and Liao River of north China. Sci. Total Environ. 2010, 408:3139-3147.
2. Comeau F., Surette C., Brun G.L., Losier R. The occurrence of acidic drugs and caffeine in sewage effluents and receiving waters from three coastal watersheds in Atlantic Canada. Sci. Total Environ. 2008, 396:132-146.
3. Nakada N., Tanishima T., Shinohara H., Kiri K., Takada H. Pharmaceutical chemicals and endocrine disrupters in municipal wastewater in Tokyo and their removal during activated sludge treatment. Water Res. 2006, 40:3297-3303.
4. Lishman L., Smyth S.A., Sarafin K., Kleywegt S., Toito J. Occurrence and reductions of pharmaceuticals and personal care products and estrogens by municipal wastewater treatment plants in Ontario, Canada. Sci. Total Environ. 2006, 367:544-558.
5. Ternes T.A. Occurrence of drugs in German sewage treatment plants and rivers. Water Res. 1998, 32:3245-3260.
6. Lee H.B., Peart T.E., Svoboda M.L. Determination of ofloxacin, norfloxacin, and ciprofloxacin in sewage by selective solid-phase extraction, liquid chromatography with fluorescence detection, and liquid chromatography-tandem mass spectrometry. J. Chromatogr. A 2007, 1139:45-52.
7. Ferrari B., Paxeus N., Giudice R.L., Pollio A., Grric J. Ecotoxicological impact of pharmaceuticals found in treated wastewaters: study of carbamazepine, clofibric acid, and diclofenac. Ecotoxicol. Environ. Saf. 2003, 55(3):359-370.
8. Jjemba P.K. Excretion and ecotoxicity of pharmaceutical and personal care products in the environment. Ecotoxicol. Environ. Saf. 2006, 63(1):113-130.
9. Grung M., Kallqvist T., Sakshaug S., Skurtveit S., Thomas K.V. Environmental assessment of Norwegian priority pharmaceuticals based on the EMEA guideline. Ecotoxicol. Environ. Saf. 2008, 71(2):328-340.
10. Daughton C.G., Ternes T.A. Pharmaceuticals and personal care products in the environment: agents of subtle change?. Environ. Health Perspect. 1999, 107(S6):907-938.
11. Schwarzenbach R.P., Escher B.I., Fenner K., Hofstetter T.B., Johnson C.A., Von Gunten U., Wehrli B. The challenge of micropollutants in aquatic systems. Science August 25 2006, 313:1072-1077.
12. Paxeus N. Removal of selected non-steroidal anti-inflammatory drugs (NSAIDs), gemfibrozil, carbamazepine, beta-blockers, trimethoprim and triclosan in conventional wastewater treatment plants in five EU countries and their discharge to the aquatic environment. Water Sci. Technol. 2004, 50(5):253-260.
13. Castiglioni S., Bagnati R., Fanelli R., Pomati F., Calamari D. Removal of pharmaceuticals in sewage treatment plants in Italy. Environ. Sci. Technol. 2006, 40(1):357-363.
14. Siegrist H., Joss A. Review on the fate of organic micropollutants in wastewater treatment and water reuse with membranes. Water Sci. Technol. 2012, 66(6):1369-1376.
15. Santos J.L., Aparicio I., Alonso E. Occurrence and risk assessment of pharmaceutically active compounds in wastewater treatment plants. A case study: Seville city (Spain). Environ. Int. 2007, 33(4):596-601.
16. Okuda T., Kobayashi Y., Nagao R., Yamashita N., Tanaka H. Removal efficiency of 66 pharmaceuticals during wastewater treatment process in Japan. Water Sci. Technol. 2008, 57(1):65-71.
17. Comerton A.M., Andrews R.C., Bagley D.M., Hao C.Y. The rejection of endocrine disrupting and pharmaceutically active compounds by NF and RO membranes as a function of compound and water matrix properties. J. Membr. Sci. 2008, 313(1-2):323-335.
18. Snyder S.A., Adham S., Redding A.M., Cannon F.S., DeCarolis J. Role of membranes and activated carbon in the removal of endocrine disruptors and pharmaceuticals. Desalination 2007, 202:156-181.
19. Westerhoff P., Yoon Y., Snyder S., Wert E. Fate of endocrine-disruptor, pharmaceutical, and personal care product chemicals during simulated drinking water treatment processes. Environ. Sci. Technol. 2005, 39:6649-6663.
20. Jiang J.-Q. Research progress in the use of ferrate(VI) for the environmental remediation. J. Hazard. Mater. 2007, 146:617-623.
21. Jiang J.-Q. Development of coagulation theory and pre-polymerised coagulants for water treatment. Sep. Purif. Methods 2001, 30:127-141.
22. Jiang J.-Q., Lloyd B., Grigore L. Preparation and evaluation of potassium ferrate as an oxidant and coagulant for potable water treatment. Environ. Eng. Sci. 2001, 18:323-328.
23. Jiang J.-Q., Lloyd B. Progress in the development and use of ferrate(VI) salt as an oxidant and coagulant for water and wastewater treatment. Water Res. 2002, 36:1397-1408.
24. Filip J., Yngard R.A., Siskova K., Marusak Z., Ettler V. Mechanisms and efficiency of the simultaneous removal of metals and cyanides by using ferrate(VI): crucial roles of nanocrystalline iron achtungtrenung(III) oxyhydroxides and metal carbonates. Chem. Eur. J. 2011, 17:10097-11005.
25. Sharma V.K. Potassium ferrate(VI): an environmentally friendly oxidant. Adv. Environ. Res. 2002, 6(2):143-156.
26. Jiang J.-Q., Panagoulopoulos A., Bauer M., Pearce P. The application of potassium ferrate for sewage treatment. J. Environ. Manage. 2006, 79(2):215-220.
27. Jiang J.-Q., Wang S., Panagoulopoulos A. The role of potassium ferrate(VI) in the inactivation of Escherichia coli and in the reduction of COD for water remediation. Desalination 2007, 210:266-273.
28. Jiang J.-Q., Stanford C., Alsheyab M. The online generation and application of ferrate(VI) for sewage treatment - a pilot scale trial. Sep. Purif. Technol. 2009, 68(2):227-231.
29. Stanford C., Jiang J.-Q., Alsheyab M. Electrochemical production of ferrate (iron VI): application to the wastewater treatment on a laboratory scale and comparison with iron(III) coagulant. Water Air Soil Pollut. 2010, 209:483-488.
30. Jiang J.-Q., Stanford C., Mollazeinal A. The application of ferrate for sewage treatment: pilot- to full-scale trials. Global NEST J. 2012, 14(1):93-99.
31. Jiang J.-Q., Wang S. Enhanced coagulation with potassium ferrate(VI) for removing humic substances. Environ. Eng. Sci. 2003, 20:627-635.
32. Jiang J.-Q., Wang S., Panagoulopoulos A. The exploration of potassium ferrate(VI) as a disinfectant/coagulant in water and wastewater treatment. Chemosphere 2006, 63:212-219.
33. Sharma V.K., Sohn M., Anquandah G.A.K., Nesnas N. Kinetics of the oxidation of sucralose and related carbohydrates by ferrate(VI). Chemosphere 2012, 87:644-648.
34. Sharma V.K. Oxidation of nitrogen-containing pollutants by novel ferrate(VI) technology: a review. J. Environ. Sci. Health, A: Toxic/Hazard. Subst. Environ. Eng. 2010, 45(6):645-667.
35. Jiang J.-Q., Yin Q., Zhou J.L., Pearce P. Occurrence and treatment trials of endocrine disrupting chemicals (EDCs) in wastewaters. Chemosphere 2005, 61(4):544-550.
36. Seitz W., Jiang J.-Q., Schulz W., Weber W.H., Maier D. Formation of oxidation by-products of the iodinated X-ray contrast medium iomeprol during ozonation. Chemosphere 2008, 70(7):1238-1246.
37. Yang B., Ying G.-G., Zhao J.-L., Liu S., Zhou L.-J. Removal of selected endocrine disrupting chemicals (EDCs) and pharmaceuticals and personal care products (PPCPs) during ferrate(VI) treatment of secondary wastewater effluents. Water Res. 2012, 46:2194-2204.
38. Anquandah G.A.K., Sharma V., Knight A.D., Batchu S.R., Gardinali P.R. Oxidation of trimethoprim by ferrate(VI): kinetics, products, and antibacterial activity. Environ. Sci. Technol. 2011, 45:10575-10581.
39. Sharma V., Luther G.W., Millero F.J. Mechanisms of oxidation of organosulfur compounds by ferrate(VI). Chemosphere 2011, 82:1083-1089.
40. Sharma V.K., Li X.Z., Graham N., Doong R.A. Ferrate(VI) oxidation of endocrine disruptors and antimicrobials in water. Water Supply Res. Technol. - AQUA 2008, 57(6):419-426.
41. Lee Y., Zimmermann S.G., Kieu A.T., von Gunten U. Ferrate (Fe(VI)) application for municipal wastewater treatment: a novel process for simultaneous micropollutant oxidation and phosphate removal. Environ. Sci. Technol. 2009, 43:3831-3838.
42. Eaton R.C., Farley R.D. Spawning cycle and egg production of zebrafish, Brachydanio rerio, in the laboratory. Copeia 1974, 1:195-209.
43. Coverdale L.E., Lean D., Martin C.C. Not just a fishing trip - environmental genomics using zebrafish. Curr. Genomics 2004, 5:395-407.
44. Goldsmith P. Zebrafish as a pharmacological tool: the how, why and when. Curr. Opin. Pharmacol. 2004, 4:504-512.
45. Hill A.J., Teraoka H., Heideman W., Peterson R.E. Zebrafish as a model vertebrate for investigating chemical toxicity. Toxicol. Sci. 2005, 86:6-19.
46. Zhou Z., Jiang J.-Q. Detection of ibuprofen and ciprofloxacin by solid phase extraction and UV/Vis spectroscopy. J. Appl. Spectrosc. 2012, 79(3):477-481.
47. Jiang J.-Q., Zhou Z., Pahl O. Preliminary study of ciprofloxacin (CIP) removal by potassium ferrate(VI). Sep. Purif. Technol. 2012, 88:95-98.
48. Sharma V.K., Mishra S.K. Ferrate(VI) oxidation of ibuprofen: a kinetic study. Environ. Chem. Lett. 2006, 3:182-185.
49. Hu L., Martin H.M., Arce-Bulted O., Sugihara M.N., Keating K.A. Oxidation of carbamazepine by Mn(VII) and Fe(VI): reaction kinetics and mechanism. Environ. Sci. Technol. 2009, 43:509-515.
50. Sharma V.K., Burnett C.R., Millero F.J. Dissociation constants of the monoprotic ferrate(VI) ion in NaCl media. Phys. Chem. Chem. Phys. 2001, 3:2059-2062.